MENU
PTIX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Protagenic Therapeutics (PTIX) Ownership - Who owns Protagenic Therapeutics?
Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders... Show more
Profile
Industry
N/A
Address
149 Fifth Avenue
Phone
+1 212 994-8200
Employees
3
Web
https://www.protagenic.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
3.21M
P/E Ratio
N/A
Total Cash
872.96K
Projected Growth
N/A
Total Debt
419.76K
Revenue
N/A
Risk (Beta)
1.57
Dividend Yield
N/A
Total Cash/Share
1.01
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
PTIX
Capitalization
3.21M
P/E Ratio
N/A
Risk (Beta)
1.57
Dividend Yield
N/A
Total Cash
873K
Total Cash/Share
1.01
Total Debt
420K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
-88.33K
P/B Ratio
1.61
Cash Flow
N/A
Earnings
-13.13
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
54
Current Ratio
0.86
Current Revenue Per Employee
300634.16
Dividends Per Share - Security
N/A
EBITDA
-5.18M
Float
N/A
Float - Current
N/A
Gross Income Margin
-5.50
Revenue To Assets
-293.85
Shares Held By Institutions
63.2K
Shares Outstanding - Current
868K
Total Liabilities
1.08M
Total Volume MTD
N/A
Value
1
Gain YTD
-46.064
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
149 Fifth Avenue
Phone
+1 212 994-8200
Employees
3
Web
https://www.protagenic.com